Laboratorio Reig Jofre, S.A. (LON:0RB1)

Market Cap	210.39M
Revenue (ttm)	284.78M
Net Income (ttm)	9.09M
Shares Out	n/a
EPS (ttm)	n/a
PE Ratio	23.15
Forward PE	16.72
Dividend	0.03 (1.11%)
Ex-Dividend Date	May 15, 2025

Volume	52
Average Volume	171
Open	3.010
Previous Close	3.030
Day's Range	3.010 - 3.010
52-Week Range	2.500 - 3.380
Beta	0.92
RSI	47.03
Earnings Date	Jul 25, 2025

About Laboratorio Reig Jofre

Laboratorio Reig Jofre, S.A., a pharmaceutical company, engages in the research, development, manufacture, and marketing of pharmaceutical products and specialties, as well as accessories authorized foodstuffs, dietary and personal care products, and cosmetics. The company offers nutritional and parapharmacy products. Its products also include pharmaceutical technologies products, such as antibiotics, and injectables and other products; specialty pharmacare products, which include skin, hair, nails, joint health and pain, and women’s health; an...

• Industry: Medicinal Chemicals and Botanical Products
• Founded: 1929
• Employees: 1,331
• Stock Exchange: London Stock Exchange
• Ticker Symbol: 0RB1

Financial Performance

In 2024, Laboratorio Reig Jofre's revenue was 338.90 million, an increase of 6.59% compared to the previous year's 317.95 million. Earnings were 10.47 million, an increase of 11.27%.

Financial numbers in EUR